3004.T

The company maintains a capital structure with a debt-to-equity ratio of 1.53, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 1.3, suggesting a limited ability to cover short-term obligations with current assets. The company's free cash flow of 1.23 billion JPY supports operational flexibility, though its net cash position is negative after subtracting total debt.

Profitability metrics show a return on equity of 15.04% and a return on assets of 4.79%, which are key indicators of the company's efficiency in generating returns for shareholders and asset utilization. These figures should be compared against the industry's preferred metrics to assess relative performance.

The company's revenue is primarily concentrated in the Food & Drug Retailing segment, with no disclosed geographic breakdown. This concentration may expose the company to specific market risks, particularly in its primary operating region.

The company's growth trajectory is reflected in its recent financial performance, with a revenue of 40.16 billion JPY. The outlook for the current fiscal year indicates a continuation of this trend, supported by the company's operating cash flow and free cash flow.

Risk factors include a medium liquidity risk, as indicated by the current ratio and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. The company's risk assessment also highlights the importance of monitoring its debt levels and liquidity position.

Recent events, including analyst estimates and financial filings, suggest a stable performance with the last actual EPS at 324.81 JPY and revenue at 40.16 billion JPY. These figures align with the company's reported financials and indicate a consistent performance.